Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Polycystic Ovary Syndrome 6Obesity 2Hyperandrogenism 1

Interventions

Exercise 24Metformin 19Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 7Surveys and Questionnaires 6semaglutide 5Liraglutide 5Exenatide 5Early Intervention, Educational 5Diet, Mediterranean 5Caloric Restriction 5Blood Specimen Collection 5Educational Status 4Bariatric Surgery 4Vitamin D 3Sugars 3Standard of Care 3Naltrexone 3Letrozole 3Docosahexaenoic Acids 3Dexamethasone 3Bupropion 3exemestane 2bupropion hydrochloride, naltrexone hydrochoride drug combination 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Obesity × Ovidrel × Clear all
NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡